Varicella zoster infections in children with acute lymphoblastic leukemia

Pediatr Hematol Oncol. 1996 May-Jun;13(3):231-8. doi: 10.3109/08880019609030821.

Abstract

During the period July 1986 through December 1991, 67 children were treated for non-B-cell acute lymphoblastic leukemia at The Juliane Marie Centre, GGK, The University Hospital Rigshospitalet, Copenhagen. Twenty-five children were susceptible to varicella zoster (VZ) virus at diagnosis. For these patients the cumulated risk of VZ exposure was 90% after 32 months. Five patients developed varicella (two of whom had pneumonitis) during the period of antileukemic treatment. Two of these had received prophylactic treatment with acyclovir. The 2 year cumulated risk of having chickenpox or herpes zoster in children with previous VZ infection was 24% and 34%, respectively. VZ vaccination ought to be considered for this group of children in order to diminish transmission and morbidity.

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chickenpox / epidemiology*
  • Child
  • Child, Preschool
  • Disease Susceptibility
  • Female
  • Follow-Up Studies
  • Herpes Zoster / epidemiology*
  • Humans
  • Male
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Probability
  • Remission Induction
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Mercaptopurine
  • Methotrexate